Bone Density Test Market Share

ID: MRFR/LS/3340-HCR

110 Pages

Kinjoll Dey

October 2025

Bone Density Test Market Research Report Information: By Type (Central Dual-Energy X-Ray Absorptiometry (DXA), Radiographic Absorptiometry), Indication (Osteoporosis, Hyperthyroidism), Device (Central DEXA Scan Machine), End User (Hospitals) - Forecast Till 2035

Summary Table of Contents Segmentation Download PDF

Market Share

Bone Density Test Market Share Analysis

People who work in health care are taught by their employers. It is easier to use and understand bone density tests when you get training, go to classes, and use learning tools. Doctors will trust the company more if it acts in this way because it makes them look like experts in the field. Different companies make different bone density tests so that doctors and people can find the right one for them. Two methods being worked on that don't use DXA are peripheral quantitative computed tomography and quantitative ultrasound. Giving people a lot of testing choices helps people get better care and makes you more desirable. It's very important to do professional review and follow the rules. To make sure that bone density tests are accurate and dependable, companies put a lot of weight on certificates and clinical studies. The market is more open to new technologies when they are clinically approved and follow the rules. It is important to check out markets in other countries. For businesses to become well-known, they go to big towns with different health care systems and rules. Globalization increases market share by giving businesses more customers and ways to make money. Companies do a lot to make sure that bone density test results are synced with EHR systems so that patients get better care and data can flow more easily. Interoperability makes it easier for nurses and doctors to talk to each other, and it also supports bone density tests to be done in real life. Getting the word out about osteoporosis and bone density tests is important. People are made more aware of the risks of low bone density and how to spot it early through focused ads. Both health care workers and customers like this method, which changes how the market sees it. Cheap bone density tests are now possible thanks to a smart mix. To get good prices, businesses use economies of scale, improve the way they make things, and negotiate with their providers. This method appeals to people who work in healthcare and groups that want to find accurate, low-cost tests. It takes time and effort to get customer feedback and improve bone density tests kits. Businesses improve their study tools based on what patients and doctors say about them. Designing goods with the user in mind makes clients pleased over time and helps a company stand out in the market.

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

FAQs

What is the projected market valuation of the Bone Density Test Market by 2035?

The Bone Density Test Market is projected to reach approximately 2.037 USD Billion by 2035.

What was the market valuation of the Bone Density Test Market in 2024?

In 2024, the market valuation of the Bone Density Test Market was 1.22 USD Billion.

What is the expected CAGR for the Bone Density Test Market during the forecast period 2025 - 2035?

The expected CAGR for the Bone Density Test Market during the forecast period 2025 - 2035 is 4.77%.

Which segment is anticipated to have the highest valuation in the Bone Density Test Market by 2035?

The Osteoporosis Diagnosis segment is anticipated to reach approximately 0.92 USD Billion by 2035.

What are the key players in the Bone Density Test Market?

Key players in the Bone Density Test Market include Hologic, GE Healthcare, Siemens Healthineers, and Philips Healthcare.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Bone Density Test Market Size was estimated at 1.22 USD Billion in 2024. The Bone Density Test industry is projected to grow from 1.278 USD Billion in 2025 to 2.037 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.77 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Bone Density Test Market is experiencing robust growth driven by technological advancements and increasing health awareness.

North America remains the largest market for bone density tests, driven by a high prevalence of osteoporosis.
The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising health awareness and an aging population.
DXA systems dominate the market, while peripheral bone densitometers are witnessing the fastest growth due to their portability and ease of use.
Key market drivers include the aging population and the rising incidence of osteoporosis, which are significantly influencing demand.

Bone Density Test Market

CAGR

4.77%

Market Size & Forecast

2024 Market Size	1.22 (USD Billion)
2035 Market Size	2.037 (USD Billion)
CAGR (2025 - 2035)	4.77%
Largest Regional Market Share in 2024	Asia Pacific

Major Players

Hologic (US), GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Fujifilm Holdings Corporation (JP), Medtronic (IE), Canon Medical Systems (JP), Bracco Imaging (IT), Agfa-Gevaert Group (BE)

Market Trends

The Bone Density Test Market is currently experiencing notable growth, driven by an increasing awareness of osteoporosis and related conditions. As populations age, the demand for diagnostic tools that assess bone health is rising. Healthcare providers are emphasizing preventive measures, leading to a greater focus on early detection of bone density issues. This trend is further supported by advancements in technology, which enhance the accuracy and efficiency of testing methods. Moreover, the integration of telemedicine is facilitating access to bone density testing, particularly in remote areas, thereby expanding the market reach. In addition, the Bone Density Test Market is witnessing a shift towards more patient-centric approaches. Patients are becoming more informed about their health, prompting healthcare professionals to adopt more personalized testing and treatment plans. This shift is likely to encourage the development of innovative testing solutions that cater to individual needs. Furthermore, collaborations between technology firms and healthcare providers are expected to foster the creation of advanced diagnostic tools, potentially transforming the landscape of bone health assessment. Overall, the Bone Density Test Market appears poised for continued expansion as it adapts to the evolving needs of patients and healthcare systems.

Technological Advancements

The Bone Density Test Market is benefiting from rapid technological innovations. New imaging techniques and devices are enhancing the precision of bone density assessments, allowing for earlier detection of osteoporosis and other conditions. These advancements not only improve diagnostic accuracy but also streamline the testing process, making it more efficient for both patients and healthcare providers.

Increased Health Awareness

There is a growing awareness regarding bone health among the general population. Educational campaigns and healthcare initiatives are informing individuals about the risks associated with low bone density. This heightened awareness is driving more people to seek testing, thereby expanding the market and encouraging preventive healthcare practices.

Patient-Centric Approaches

The Bone Density Test Market is increasingly adopting patient-centric strategies. Healthcare providers are focusing on personalized care, tailoring testing and treatment plans to meet individual patient needs. This trend is likely to enhance patient engagement and satisfaction, ultimately leading to better health outcomes and a more robust market.

Bone Density Test Market Market Drivers

Aging Population

The increasing proportion of elderly individuals in various regions appears to be a primary driver for the Bone Density Test Market. As age is a significant risk factor for osteoporosis and other bone-related disorders, the demand for bone density testing is likely to rise. According to recent statistics, approximately 54 million individuals in the United States alone are estimated to have low bone density, which underscores the necessity for regular screening. This demographic shift necessitates enhanced healthcare services, including preventive measures and early diagnosis, thereby propelling the growth of the Bone Density Test Market. Furthermore, healthcare providers are increasingly recognizing the importance of early intervention, which may lead to a greater emphasis on bone density testing as part of routine health assessments for older adults.

Technological Innovations

Technological advancements in diagnostic imaging and testing methodologies are poised to significantly influence the Bone Density Test Market. Innovations such as dual-energy X-ray absorptiometry (DEXA) and quantitative computed tomography (QCT) have improved the accuracy and efficiency of bone density assessments. These technologies not only provide precise measurements but also enhance patient comfort and reduce testing time. The market for bone density testing equipment is projected to grow, with estimates suggesting a compound annual growth rate of around 5% over the next few years. As healthcare facilities adopt these advanced technologies, the Bone Density Test Market is likely to experience increased demand, driven by both healthcare providers and patients seeking reliable diagnostic options.

Increased Health Awareness

The growing awareness of health and wellness among the general population is significantly impacting the Bone Density Test Market. Individuals are becoming more proactive about their health, seeking preventive measures to avoid chronic conditions such as osteoporosis. Educational campaigns and initiatives by health organizations are contributing to this trend, emphasizing the importance of bone health and the role of regular testing. As a result, more people are likely to request bone density tests as part of their routine health check-ups. This shift in consumer behavior is expected to drive demand within the Bone Density Test Market, as healthcare providers adapt to meet the needs of an increasingly health-conscious population.

Rising Incidence of Osteoporosis

The escalating prevalence of osteoporosis and related conditions is a critical factor driving the Bone Density Test Market. Osteoporosis affects millions worldwide, with estimates indicating that one in three women and one in five men over the age of 50 will experience a fracture due to this condition. This alarming trend has prompted healthcare systems to prioritize bone health, leading to an increased focus on preventive measures, including regular bone density testing. As awareness of osteoporosis grows, more individuals are likely to seek testing, thereby expanding the market. Additionally, healthcare policies that promote early diagnosis and treatment of osteoporosis are expected to further stimulate the Bone Density Test Market, as they encourage routine screenings and proactive management of bone health.

Patient-Centric Healthcare Models

The transition towards patient-centric healthcare models is reshaping the Bone Density Test Market. These models prioritize patient engagement and personalized care, encouraging individuals to take an active role in their health management. As healthcare providers adopt these approaches, there is a growing emphasis on preventive care, including regular bone density assessments. This shift is likely to lead to increased testing rates, as patients become more informed about their health risks and the importance of early detection. Furthermore, healthcare systems are increasingly integrating bone density testing into routine screenings, which may enhance accessibility and convenience for patients. Consequently, the Bone Density Test Market is expected to benefit from this trend, as patient-centric models promote a culture of proactive health management.

Market Segment Insights

By Type: DXA Systems (Largest) vs. Peripheral Bone Densitometers (Fastest-Growing)

The Bone Density Test Market is primarily driven by DXA systems, which hold the largest share due to their accuracy and widespread adoption in clinical practice. Peripheral Bone Densitometers are emerging as a fast-growing segment, catering to both clinical and home-use settings, thus expanding their market reach. This shift indicates the increasing demand for accessible bone health testing and the rising prevalence of osteoporosis, which necessitates regular monitoring. Growth trends indicate a significant rise in the adoption of Peripheral Bone Densitometers prompted by technological advancements and increased awareness of bone health among the aging population. Simultaneously, DXA systems are seeing sustained utilization in medical facilities due to their proven efficacy and credentialed results. The continuous innovations in imaging technology are likely to further drive the development and refinement of both DXA and peripheral systems in the foreseeable future.

DXA Systems (Dominant) vs. Radiographic Absorptiometry Scanners (Emerging)

DXA systems are recognized for their reliability and precision in measuring bone mineral density, thus establishing themselves as the dominant force in the Bone Density Test Market. Their robust integration into clinical protocols has made them the gold standard for osteoporosis and fracture risk assessment. In comparison, Radiographic Absorptiometry Scanners are emerging contenders that utilize X-ray technology to assess bone density, appealing to a niche market looking for lower-cost solutions and requiring less technical expertise. While DXA systems are preferred in specialist medical environments, the versatility and cost-effectiveness of Radiographic Absorptiometry make them an appealing option for smaller practices and varied diagnostic settings.

By Application: Osteoporosis Diagnosis (Largest) vs. Body Composition Measurement (Fastest-Growing)

In the Bone Density Test Market, the application segment is characterized by its diversified use across several domains, with Osteoporosis Diagnosis holding the largest market share. This segment is predominantly driven by the aging population and increasing awareness regarding bone health. Other significant applications include Cystic Fibrosis Diagnosis and Rheumatoid Arthritis Diagnosis, which contribute to the overall market, yet lag in comparison to osteoporosis evaluations. Body Composition Measurement is emerging as a noteworthy application, catering to a growing interest in holistic health assessments and fitness tracking. Growth trends within the Bone Density Test Market show a positive trajectory for both established and emerging applications. The demand for Osteoporosis Diagnosis continues to surge due to the rising prevalence of osteoporosis, particularly among older adults. Concurrently, Body Composition Measurement is gaining traction, fueled by a cultural shift towards personalized medicine and preventive healthcare approaches. Factors such as technological advancements in bone density testing and an increased focus on preventive health measures are vital drivers for this segment's growth.

Osteoporosis Diagnosis (Dominant) vs. Body Composition Measurement (Emerging)

Osteoporosis Diagnosis remains the dominant application in the Bone Density Test Market, reflecting its critical role in preventative healthcare for the elderly demographic. This segment is robust due to its established methodologies, widespread clinical acceptance, and the growing recognition of osteoporosis's long-term health impacts. In contrast, Body Composition Measurement is an emerging segment, capitalizing on the proactive health and fitness trends among younger populations. This application utilizes advanced imaging technologies to provide insights beyond mere bone density, addressing the comprehensive health concerns of individuals. As awareness of bone health advances, both segments are expected to coexist, with osteoporosis remaining pivotal while body composition measurement expands into new health-conscious markets.

By End-User: Hospitals and Specialty Clinics (Largest) vs. Diagnostic and Imaging Centers (Fastest-Growing)

In the Bone Density Test Market, hospitals and specialty clinics account for a substantial portion of the end-user segment. These facilities are equipped with advanced technologies and trained personnel, enabling them to provide comprehensive bone health assessment services. The prevalence of osteoporosis and related conditions drives the demand for bone density testing in these settings, which offer timely diagnostic and treatment solutions for patients. Conversely, diagnostic and imaging centers are emerging as pivotal players in the market, witnessing rapid growth as they increasingly adopt innovative imaging techniques and expand their service offerings. This trend is attributed to the rising awareness of bone health and the growing number of preventative health screenings.

Hospitals and Specialty Clinics (Dominant) vs. Diagnostic and Imaging Centers (Emerging)

Hospitals and specialty clinics are regarded as the dominant end-users in the Bone Density Test Market due to their extensive patient reach and comprehensive healthcare services. These institutions often possess state-of-the-art equipment for accurate bone density measurements, ensuring effective clinical outcomes. On the other hand, diagnostic and imaging centers are emerging as significant players, focusing on specialized health services and advanced imaging modalities. Their rapid growth is driven by an increased emphasis on preventive healthcare and the convenience these centers offer to patients seeking specialized diagnostic services. In this evolving landscape, both segments are crucial for delivering quality bone health assessments.

Get more detailed insights about Bone Density Test Market Research Report - Forecast till 2035

Regional Insights

North America : Leading Market for Innovation

North America is the largest market for bone density tests, holding approximately 45% of the global market share. The region's growth is driven by an aging population, increasing prevalence of osteoporosis, and advancements in diagnostic technologies. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring that innovative products meet safety and efficacy standards. The United States is the primary contributor, with significant investments in healthcare infrastructure and technology. Key players such as Hologic and GE Healthcare lead the competitive landscape, focusing on innovative solutions and strategic partnerships. The presence of advanced healthcare facilities and a strong emphasis on preventive care further bolster market growth in this region.

Europe : Regulatory Framework Enhances Growth

Europe is the second-largest market for bone density tests, accounting for around 30% of the global share. The region benefits from a robust regulatory framework that encourages innovation and ensures high-quality healthcare services. Increasing awareness about bone health and the rising incidence of osteoporosis among the aging population are key growth drivers. Additionally, government initiatives aimed at improving healthcare access contribute to market expansion. Leading countries include Germany, France, and the UK, where healthcare systems are increasingly adopting advanced diagnostic technologies. Major players like Siemens Healthineers and Philips Healthcare are actively involved in research and development, enhancing their product offerings. The competitive landscape is characterized by collaborations and partnerships aimed at improving patient outcomes and expanding market reach.

Asia-Pacific : Emerging Market with High Potential

Asia-Pacific is an emerging powerhouse in the bone density test market, holding approximately 20% of the global share. The region's growth is fueled by increasing healthcare expenditure, rising awareness of osteoporosis, and a growing elderly population. Countries like China and India are witnessing a surge in demand for diagnostic services, supported by government initiatives aimed at enhancing healthcare infrastructure. China is the largest market in the region, with significant investments in healthcare technology and a focus on preventive care. Key players such as Fujifilm and Canon Medical Systems are expanding their presence through strategic partnerships and localized product offerings. The competitive landscape is evolving, with both established companies and new entrants vying for market share, driven by innovation and affordability.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is witnessing a gradual increase in the bone density test market, currently holding about 5% of the global share. The growth is primarily driven by rising healthcare investments, increasing awareness of osteoporosis, and a growing population at risk. Governments are focusing on improving healthcare access and quality, which is expected to further stimulate market growth in the coming years. Countries like South Africa and the UAE are leading the market, with significant investments in healthcare infrastructure and technology. The competitive landscape includes both local and international players, with companies like Bracco Imaging and Agfa-Gevaert Group making strides in the region. The focus on enhancing diagnostic capabilities and patient care is shaping the future of the market in this region.

Key Companies in the Bone Density Test Market market include

Industry Developments

According to the International Osteoporosis Foundation, and the circulated stats, osteoporosis is known to be causing more than 8.9 million fractures annually. This means that an osteoporotic fracture tends to happen every 3 seconds across the globe. It also stated as per the circulated facts that osteoporosis is affected at an estimated 75 million people in geographical regions like the European countries, the US, and Japan.
In May 2019, one of the prominent market players - DEX+ entered into an agreement with Hologic for the distribution of its products. These products are used for body composition measurement.
In 2018, the hospitals and specialty clinics accounted for the largest market share in the global market premises, and this trend is expected to continue during the forecast period of 2021-2028. The majority of bone density scans are conducted and performed in hospitals owing to the higher degree of preference of patients for hospital-based treatments that include the monitoring for diseases such as cystic fibrosis, chronic kidney diseases, and osteoporosis.

Intended Audience

Drug producers, wholesalers, and manufacturers
Drug dealers and suppliers
Medical Research firms and laboratories
Research and Development (R&D) Companies and organizations
Market Research and Consulting Service Providers
Potential Investors, retailers, and buyers of the market

Future Outlook

Bone Density Test Market Future Outlook

The Bone Density Test Market is projected to grow at a 4.77% CAGR from 2024 to 2035, driven by increasing osteoporosis prevalence, technological advancements, and rising awareness.

New opportunities lie in:

Expansion of telehealth services for remote bone density testing.
Development of portable bone density testing devices for home use.
Partnerships with healthcare providers for integrated diagnostic solutions.

By 2035, the Bone Density Test Market is expected to achieve substantial growth and innovation.

Market Segmentation

Study Objectives

The report aims to further
concentrate on the rising serious degree in the worldwide market situation dependent on the pooled endeavors delivered by the key market players as the new improvements attempted by them during the ongoing forecast period that finishes in 2030.
The report aims to concentrate on the rising necessities of the interest group that is spread across the worldwide scale which further
leads to the market patterns for the ongoing forecast period that finishes in 2028. Further
the report has a target to concentrate on the premise on which the worldwide market has been bifurcated and the assets accessible that will assist the market with developing per the figures anticipated by the business chiefs for the period.
The bone density test market aims to investigate the past patterns of the market tasks followed by the effect of the Covid flare-up on the working of the market. Further
the report expects to feature the elements accessible to the market as drivers that will lead the way of the players towards monstrous worldwide extension and talk about the potential downsides and limitations that will deliver obstacles for the market in transit of its development.

Intended Audience

Drug producers
wholesalers
and manufacturers
Drug dealers and suppliers
Medical Research firms and laboratories
Research and Development (R&D) Companies and organizations
Market Research and Consulting Service Providers
Potential Investors
retailers
and buyers of the market

Recent Developments

According to the International Osteoporosis Foundation
and the circulated stats
osteoporosis is known to be causing more than 8.9 million fractures annually. This means that an osteoporotic fracture tends to happen every 3 seconds across the globe. It also stated as per the circulated facts that osteoporosis is affected at an estimated 75 million people in geographical regions like the European countries
the US
and Japan.
In May 2019
one of the prominent market players - DEX+ entered into an agreement with Hologic for the distribution of its products. These products are used for body composition measurement.
In 2018
the hospitals and specialty clinics accounted for the largest market share in the global market premises
and this trend is expected to continue during the forecast period of 2021-2028. The majority of bone density scans are conducted and performed in hospitals owing to the higher degree of preference of patients for hospital-based treatments that include the monitoring for diseases such as cystic fibrosis
chronic kidney diseases
and osteoporosis.

Key Players in the Global Bone Density Test Market

Echolight S.P.A (Italy)
Nanoomtech Co.
Ltd. (South Korea)
L’acn L’accessorio Nucleare S.R.L (Italy)
Scanflex Healthcare AB (Sweden)
Eurotec Systems S.r.l (Italy)

Report Scope

MARKET SIZE 2024	1.22(USD Billion)
MARKET SIZE 2025	1.278(USD Billion)
MARKET SIZE 2035	2.037(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	4.77% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Integration of advanced imaging technologies enhances accuracy in the Bone Density Test Market.
Key Market Dynamics	Rising demand for advanced imaging technologies drives innovation and competition in the Bone Density Test Market.
Countries Covered	North America, Europe, APAC, South America, MEA